Feds arrest top official of healthcare company, alleging illegal drug importation

Federal prosecutors arrested two senior executives of a Canadian prescription-drug supplier, alleging they ran a scheme to import medicines into the U.S. without regulatory approval. The case targets the company’s top leadership and challenges the legal basis for cross-border drug shipments. It matters because U.S. patients and payers have increasingly relied on Canadian suppliers for lower-priced medicines. Watch whether regulators tighten import rules and whether the company can keep shipping while the case proceeds.